Skip to main content
CAPR
NASDAQ Life Sciences

HOPE-3 Cardiac Endpoint Misses Significance, Tempering Deramiocel Data

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$9.083
Mkt Cap
$523.251M
52W Low
$2.96
52W High
$40.37
52W Position info
207% above low
Off High info
78% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

CAPR has more than doubled off its 52-week low of $2.96.

Summary

The HOPE-3 key secondary endpoint — change in LVEF across all patients — came in at p=0.09, missing statistical significance. That undercuts the cardiac side of the deramiocel story, which had been a supporting pillar after the trial hit its primary upper limb function endpoint (PUL 2.0, p=0.029) in August. The trial randomized 106 patients over 12 months, so the evidence base is small and the cardiac readout is now the weak link. The BLA remains under FDA review with a PDUFA target action date of November 22, 2026 — that decision is the binary event that matters, and it is now roughly two weeks out. This follows the August 24 three-month PDUFA extension and the 24-month open-label data presented in late September and early October.

At the time of this announcement, CAPR was trading at $9.08 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $523.3M. The 52-week trading range was $2.96 to $40.37. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

CAPR - Latest Insights

CAPR
Nov 10, 2026, 5:25 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $9.35
Real-time Price: $10.65 info
Change: +$1.30 (+14%) info
Market Cap: $618.89M info
CAPR
Nov 10, 2026, 5:01 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $9.10
Real-time Price: $10.65 info
Change: +$1.55 (+17%) info
Market Cap: $618.89M info
CAPR
Nov 10, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.91
Real-time Price: $10.65 info
Change: +$1.74 (+20%) info
Market Cap: $618.89M info
CAPR
Oct 05, 2026, 12:12 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $8.22
Real-time Price: $10.65 info
Change: +$2.42 (+30%) info
Market Cap: $618.89M info
CAPR
Sep 29, 2026, 9:24 PM EDT
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $10.27
Real-time Price: $10.65 info
Change: +$0.375 (+4%) info
Market Cap: $618.89M info